Health Canada approves Iovance’s Amtagvi for the treatment of advanced melanoma: San Carlos, California Wednesday, August 20, 2025, 09:00 Hrs [IST] Iovance Biotherapeutics, Inc.

A new Nature study suggests infections like influenza and COVID-19 can trigger dormant cancer cells to awaken, potentially raising the risk of recurrence and metastasis.

Kate Middleton is reportedly still "struggling" emotionally and physically despite being in remission after her cancer battle ...

Cutting off blood flow can prematurely age the bone marrow, weakening the immune system's ability to fight cancer, according ...

SELLAS Life Sciences is developing GPS as a WT1 immunotherapy, which is in Phase 3 for AML. Click here to read why SLS stock ...

In the national examination, the elderly are sometimes excluded from the subject due to efficiency issues.However, a domestic ...

Olivia Munn shared an intimate, emotional moment between herself and husband John Mulaney just moments before she underwent a ...

One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a ...

Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American ...

Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the ...

Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple ...

Researchers suggest targeting inflammation may offer a promising therapeutic strategy at the intersection of cancer and cardiovascular disease.